SpaceX's $123 Billion Lockup Cliff Meets a Record IPO Pipeline: The Supply Test Arrives Aug. 6

On August 4, SpaceX (SPCX) will report quarterly earnings for the first time as a public company. The numbers will matter — Starlink subscriber growth, AI infrastructure spending, the path to profitability. But the more consequential date is August 6, two business days later, when the first major tranche of insider lockups expires and roughly 911.5 million shares — valued at approximately $123 billion at recent prices — become eligible to trade for the first time^[1][2].

This is not a routine lockup expiration. SpaceX floated only about 5% of its shares at its June 12 IPO — roughly 629 million shares — versus the ~20% that a typical IPO sells to the public^[2]. The company then implemented what Renaissance Capital senior strategist Matthew Kennedy calls “the longest series of lock-up releases we’ve ever seen,” with tranches unlocking at staggered intervals over 180 days rather than a single cliff^[2]. By December 8, when the full lockup period concludes, roughly 40% of all SpaceX shares will be freely tradable. Elon Musk’s personal stake carries a 366-day lockup, keeping his shares locked until approximately June 2027^[1].

The staggered schedule means the supply overhang is not a single event but a rolling one. After the August 6 tranche, another 455.8 million shares unlock around August 20. Further expirations follow in September and beyond, each one an incremental test of how much paper the market can absorb^[2].

The Stock Is Already Telegraphing Stress

SpaceX’s post-IPO trajectory has been a warning signal in itself. Priced at $135, the stock rocketed above $201 in its first week before entering a sustained decline. By mid-July, shares had broken below the IPO price. On July 28, SPCX closed at $116.41, after touching an all-time intraday low of $107.01 earlier in the week — a loss of roughly 45% from the peak^[3][2].

Morningstar equity analyst Nicolas Owens believes the lockup overhang is already pricing in. “We believe that most of the available shares will come to market, because the existing sellers have low cost basis and long holding periods,” he says. “It’s conceivable that a good deal of the recent slump in SpaceX stock is precisely in anticipation of the dilution from the lockup”^[2].

The index-fund dynamic adds a second-order effect. As SpaceX’s float increases, its float-adjusted market capitalization rises, which in turn increases its weighting in cap-weighted indices. Morningstar analyst Zachary Evens notes that the Invesco QQQ Trust held roughly 39.7 million SPCX shares as of July 22, a 0.98% portfolio weight. When the float-adjusted market cap triples — as it could by the end of September — index providers would treat SpaceX as a $675 billion company, slotting it between Walmart and Intel in the Nasdaq-100^[2].

“Every lockup expiration is an opportunity for SpaceX to claim a greater share of cap-weighted index funds,” Evens says. “Typically, stocks earn a greater share of these portfolios because of rising in price. SpaceX is different; it will also claim a higher weight if its stock price increases, or if its float percentage goes up”^[2].

But Owens does not believe passive demand will be enough. “Unless something changes the fundamental story or sentiment — like for the better — the supply from these lockups will outweigh demand even from index funds,” he says^[2].

The Bigger Picture: A 23-Year Tailwind Is Ending

The SpaceX lockup cliff does not arrive in isolation. It lands atop the biggest first-half IPO market in history and a structural reversal in how US companies manage their share counts.

US issuers raised $251 billion in IPOs through June 26, 2026, surpassing the prior midyear record set during the 2021 listing boom^[4]. Two deals drove roughly 68% of that total: SpaceX’s $86.2 billion IPO and Alphabet’s $85 billion secondary equity raise to fund its AI infrastructure buildout^[4]. Even excluding those two giants, the market was broad: 11 IPOs cleared the $1 billion threshold in the first half, and 194 IPOs priced in total through July 2, raising $155.8 billion^[4][5].

Beneath the headline numbers, a deeper structural shift is underway. According to Goldman Sachs data, US net equity supply — new shares hitting the market minus equity removed by buybacks or go-privates — will be nearly flat in 2026, the first time it has not been in negative territory since 2003. By 2027, Goldman projects the figure turns meaningfully positive as lockup periods on this year’s landmark listings begin to expire^[6].

For more than two decades, the mechanical shrinkage of publicly traded share counts has been a quiet tailwind for US equities. The same pool of capital chased a shrinking number of claims on corporate earnings, pushing prices higher through denominator compression alone. That tailwind is now shutting off — and doing so at a moment when valuations remain historically elevated.

The reversal has two drivers converging simultaneously. First, the IPO supercycle: SpaceX, Anthropic, and OpenAI — three of the most anticipated listings in 20 years — are arriving in a single calendar year. Second, Big Tech is pivoting from buying back its own stock to issuing new equity. Alphabet’s $85 billion raise marked its first net equity issuance in 11 years. Meta Platforms is reportedly preparing a similarly sized offering. The four largest hyperscalers — Alphabet, Amazon, Meta, and Microsoft — have collectively announced $725 billion in planned AI infrastructure investment, diverting capital that previously funded share repurchases^[6].

Barclays global research chair Ajay Rajadhyaksha frames it plainly: “This is a sea change. It will give us a clean test case for how much of the broad stock rally over the past decade has been about a net reduction in shares”^[6].

The Anthropic-OpenAI Pipeline Hinges on SpaceX

The H2 issuance calendar is already taking shape, and its fate is partly tethered to how SpaceX trades after August 6.

Anthropic has confidentially filed its S-1 with the SEC and is targeting an IPO by October 2026, backed by a $965 billion private valuation and projected Q2 revenue of $10.9 billion. Goldman Sachs, Morgan Stanley, and JPMorgan are leading the offering, with investor meetings already underway^[7]. OpenAI has also confidentially filed but has not held pre-IPO meetings or set an official timeline; the New York Times reported the company is leaning toward a 2027 listing^[7].

ECM bankers are watching SpaceX as the bellwether. One US-based banker quoted in ION Analytics’ ECM Pulse warned: “If SpaceX starts to trade down that could close the door for other AI issuers”^[5]. Another cautioned that having both Anthropic and OpenAI list in September and October — if sentiment sours — “sounds terrible for the broader market” given that neither company has “the idiosyncratic features that the SpaceX setup had”^[5].

The concern is not abstract. Post-SpaceX, 19 IPOs have priced on US exchanges, raising approximately $6.9 billion combined — a respectable but slowing pace^[5]. The pipeline is not the problem. The question is whether investor appetite survives the supply test.

SpaceX Lockup Expiration Schedule

Sources: Morningstar, Crypto Briefing, Renaissance Capital^[2][1]

What to Watch Next

Aug 4 earnings quality. SpaceX’s first public report needs to show Starlink subscriber momentum and a credible AI infrastructure narrative. If the numbers disappoint, the lockup overhang compounds into a sell-first-ask-questions-later dynamic.

Aug 6 selling pressure. The first tranche is the largest single unlock. Watch volume, bid-ask spreads, and whether the stock can hold above its recent $107-116 trading range. A break below $100 would signal that early investors are exiting at any price.

Index rebalance timing. Index providers typically review float quarterly. The next Nasdaq-100 rebalance could meaningfully increase SPCX’s weight — forcing passive funds to buy — but the timing and magnitude are not yet clear.

Anthropic IPO reception. If Anthropic prices in October at or near its $965 billion private valuation, it will validate the AI-issuer window. If it delays or cuts its price, the signal will be that SpaceX’s lockup damage has spread.

Meta’s equity raise. A Meta secondary offering would confirm that Alphabet’s pivot was not a one-off. Each additional hyperscaler issuance deepens the structural supply shift Goldman and Barclays have flagged.

Net equity supply data. Goldman’s projection of flat-to-positive net supply in 2026-2027 is the single most important structural indicator. If Q3 data shows the flip arriving ahead of schedule, the rebalancing pressure on institutional portfolios intensifies.

This article is research commentary for educational purposes, not investment advice. Data reflects information available as of July 29, 2026.